HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Motohisa Yamamoto Selected Research

Sialadenitis

9/2019Interleukin 5-producing ST2+ memory Th2 cells in IgG4-related dacryoadenitis and sialadenitis.
11/2018Stage classification of IgG4-related dacryoadenitis and sialadenitis by the serum cytokine environment.
1/2018Clinical utility of 18 F-fluorodeoxyglucose/positron emission tomography in diagnosis of immunoglobulin G4-related sclerosing sialadenitis.
1/2016Immune complexome analysis of antigens in circulating immune complexes isolated from patients with IgG4-related dacryoadenitis and/or sialadenitis.
9/2015[IgG4-related Dacryoadenitis and Sialadenitis].
11/2014The role of cytotoxic T cells in IgG4-related dacryoadenitis and sialadenitis, the so-called Mikulicz's disease.
1/2013Long-term outcomes and necessity of early intervention for IgG4-related disease.
1/2012[Usefulness of measuring serum IgG4 level as diagnostic and treatment marker in IgG4-related disease].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Motohisa Yamamoto Research Topics

Disease

49Immunoglobulin G4-Related Disease
01/2022 - 01/2010
15Fibrosis (Cirrhosis)
01/2022 - 07/2010
15Mikulicz' Disease
11/2014 - 04/2005
10Autoimmune Pancreatitis
01/2015 - 04/2005
8Rheumatoid Arthritis
10/2020 - 01/2007
8Sialadenitis
09/2019 - 01/2012
7Dacryocystitis (Dacryoadenitis)
09/2019 - 01/2012
7Interstitial Nephritis (Tubulointerstitial Nephritis)
02/2016 - 01/2006
5Retroperitoneal Fibrosis
12/2018 - 01/2006
5Hypergammaglobulinemia (Hyperimmunoglobulinemia)
03/2018 - 10/2005
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016 - 01/2004
4Rheumatic Diseases (Rheumatism)
01/2021 - 06/2006
4Disease Progression
10/2020 - 10/2013
4Autoimmune Diseases (Autoimmune Disease)
05/2020 - 01/2013
3Inflammation (Inflammations)
01/2022 - 03/2014
3Arthritis (Polyarthritis)
10/2020 - 02/2004
3Systemic Scleroderma (Systemic Sclerosis)
01/2016 - 01/2012
3Thyroiditis
02/2012 - 01/2006
3Autoimmune Hypophysitis
02/2012 - 01/2006
3Thrombocytopenia (Thrombopenia)
12/2009 - 01/2004
2Neoplasms (Cancer)
06/2022 - 06/2012
2Osteonecrosis (Kienbock's Disease)
05/2020 - 01/2013
2Takayasu Arteritis (Arteritis, Takayasu's)
12/2018 - 01/2016
2Liver Cirrhosis (Hepatic Cirrhosis)
12/2018 - 06/2012
2B-Cell Lymphoma (Lymphoma, B Cell)
10/2017 - 01/2016
2Hypersensitivity (Allergy)
01/2016 - 12/2009
2Tuberculosis (Tuberculoses)
01/2016 - 10/2007
2Multi-centric Castleman's Disease
01/2016 - 06/2012
2Churg-Strauss Syndrome (Allergic Angiitis)
06/2012 - 01/2010
2Fever (Fevers)
12/2009 - 06/2006
2Liver Diseases (Liver Disease)
02/2004 - 01/2004
1Muscular Diseases (Myopathy)
01/2021
1Muscular Atrophy (Muscle Atrophy)
01/2021
1Sarcopenia
01/2021
1Bullous Pemphigoid (Pemphigoid)
10/2020
1Pancytopenia
10/2020
1Immune System Diseases (Immune Disorders)
05/2020
1Lymphadenopathy
12/2018
1Cholecystitis
12/2018

Drug/Important Bio-Agent (IBA)

43Immunoglobulin G (IgG)IBA
01/2022 - 02/2004
16GlucocorticoidsIBA
12/2021 - 10/2005
15Immunoglobulins (Immunoglobulin)IBA
06/2022 - 01/2006
10Adrenal Cortex Hormones (Corticosteroids)IBA
05/2020 - 12/2004
8SteroidsIBA
05/2020 - 02/2004
7DNA (Deoxyribonucleic Acid)IBA
10/2020 - 02/2004
6Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2007
5AutoantibodiesIBA
10/2020 - 02/2006
4Abatacept (Orencia)FDA Link
10/2020 - 01/2016
4InterleukinsIBA
09/2019 - 01/2016
3Rituximab (Mabthera)FDA Link
12/2021 - 08/2015
3Prednisolone (Predate)FDA LinkGeneric
01/2021 - 02/2004
3Interleukin-6 (Interleukin 6)IBA
10/2020 - 07/2009
3CytokinesIBA
11/2018 - 03/2014
3Immunoglobulin E (IgE)IBA
03/2018 - 11/2010
3Infliximab (Remicade)FDA Link
10/2007 - 06/2006
3Antinuclear AntibodiesIBA
10/2005 - 01/2004
2Pharmaceutical PreparationsIBA
10/2020 - 01/2016
2RNA (Ribonucleic Acid)IBA
05/2020 - 01/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2018 - 01/2007
2interleukin-21 (interleukin 21)IBA
11/2018 - 01/2016
2AntigensIBA
02/2017 - 01/2016
2Interferon-gamma (Interferon, gamma)IBA
06/2016 - 10/2007
2Biological ProductsIBA
01/2016 - 06/2006
2Antigen-Antibody Complex (Immune Complex)IBA
01/2016 - 01/2012
2EnzymesIBA
01/2013 - 01/2004
2TinIBA
10/2011 - 02/2010
2SS-B antibodiesIBA
07/2010 - 02/2006
1dupilumabIBA
01/2022
1CX3C Chemokine Receptor 1IBA
01/2021
1Chemokine CX3CL1IBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1Isoleucine (L-Isoleucine)FDA Link
01/2021
1Eicosapentaenoic AcidIBA
01/2021
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2021
1Amino AcidsFDA Link
01/2021
1Aspartic Acid (Aspartate)FDA Link
01/2021
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2021
1baricitinibIBA
10/2020
1Adalimumab (Humira)FDA Link
10/2020
1tocilizumab (atlizumab)FDA Link
10/2020
1bactericidal permeability increasing proteinIBA
05/2020
1Proton Pump InhibitorsIBA
05/2020
1Lansoprazole (Prevacid)FDA LinkGeneric
05/2020
1LactoferrinIBA
05/2020
1Transcobalamins (Transcobalamin II)IBA
05/2020
1Secretory Leukocyte Peptidase InhibitorIBA
05/2020
1HLA-B Antigens (HLA-B)IBA
12/2018
1procollagen Type III-N-terminal peptide (PIIP)IBA
12/2018
1Growth Differentiation Factor 15IBA
12/2018
1Tissue Inhibitor of Metalloproteinase-1IBA
12/2018
1InterferonsIBA
11/2018
1Interleukin-13IBA
11/2018
1Monocyte Chemoattractant ProteinsIBA
11/2018
1Interleukin-15 (Interleukin 15)IBA
11/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2018
1Interleukin-5 (Interleukin 5)IBA
11/2018
1Interleukin-10 (Interleukin 10)IBA
11/2018

Therapy/Procedure

15Therapeutics
12/2021 - 12/2009
3Aftercare (After-Treatment)
02/2016 - 06/2012
1Remission Induction
12/2021